Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LPTX will decline by -18.62% over the next 2 Weeks and hit $0.63 by Tuesday, March 31, 2026. In that time frame, LPTX's share price is expected to range between $0.57 and $0.69.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 31, 2026 | 0.46 | 0.54 | 0.60 |
| Mar 30, 2026 | 0.48 | 0.55 | 0.62 |
| Mar 27, 2026 | 0.46 | 0.52 | 0.59 |
| Mar 26, 2026 | 0.43 | 0.50 | 0.57 |
| Mar 25, 2026 | 0.47 | 0.54 | 0.61 |
| Mar 24, 2026 | 0.49 | 0.56 | 0.64 |
| Mar 23, 2026 | 0.51 | 0.57 | 0.64 |
| Mar 20, 2026 | 0.48 | 0.55 | 0.61 |
| Mar 19, 2026 | 0.46 | 0.53 | 0.60 |
| Mar 18, 2026 | 0.50 | 0.57 | 0.63 |
LPTX shares fell -3.15% in Wednesday, April 1, 2026's trading session, dropping from a previous close of $0.79 to move at $0.77. The stock demonstrated notable intraday movement (see LPTX's key stats for a full breakdown), fluctuating between $0.74 and $0.80, a +8.43% trading range. While recent weeks have seen some volatility, LPTX has managed to secure a +18.27% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 346.28K shares changing hands, 2.97M fewer than the previous session. This amounted to $266.50K in total market activity.
Will LPTX Continue Its Downward Trend?
According to analyst ratings and projections for LPTX, Leap Therapeutics, Inc. shares are anticipated to decrease by -27.46%, potentially reaching $0.60 per share by March 31, 2026. Short-term technical indicators currently suggest a neutral sentiment for LPTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the LPTX stock forecast, now is not the best time to buy LPTX stock because its current trading price is +43.72% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LPTX covering social and institutional perspectives.
LPTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LPTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.15% to 56.24%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.51%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.39%, maintains a neutral outlook for the long term. Insights into LPTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Leap Therapeutics, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Leap Therapeutics, Inc. (LPTX) is positioned to show a strong performance in May 2026. The price is predicted to move between $2.80 and $5.04, settling at an average of $4.00. This could translate to a +419.75% gain.
June 2026
Based on current market signals, Leap Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $1.27 to $5.14, with a likely average price of $3.79. Investors could expect a potential return of +392.46%.
July 2026
Our predictive algorithms indicate Leap Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $1.01–$2.10, with an average target of $1.92. This represents a positive outlook and a possible gain of +149.48%.
August 2026
Analyzing established trends, Leap Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $0.93 and $2.87, averaging around $2.48. This suggests a +222.25% gain from current levels.
September 2026
Market indicators suggest Leap Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.32 to $2.80, with a midpoint forecast of $2.58. The stock might deliver a +235.24% gain.
October 2026
Forecasting for October 2026, models estimate that Leap Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.24, averaging $3.09. This signals a positive trajectory with potential returns around +301.51%.
November 2026
According to our latest forecast models, Leap Therapeutics, Inc. (LPTX) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $3.89, settling at an average of $3.82. This could translate to a +396.36% gain.
December 2026
Based on current market signals, Leap Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $6.35, with a likely average price of $4.81. Investors could expect a potential return of +525.00%.
January 2027
Our predictive algorithms indicate Leap Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$8.81, with an average target of $7.08. This represents a positive outlook and a possible gain of +819.96%.
February 2027
Analyzing established trends, Leap Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $10.33, averaging around $7.46. This suggests a +869.33% gain from current levels.
March 2027
Market indicators suggest Leap Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $10.47, with a midpoint forecast of $7.07. The stock might deliver a +818.66% gain.
LPTX's history of dividends and stock splits also plays a role in long-term investor confidence.